LFUS Form 144: Restricted Stock Vesting Leads to 750-Share Sale ($190.6K)
Rhea-AI Filing Summary
Littelfuse (LFUS) Form 144 reports a proposed sale of 750 common shares with an aggregate market value of $190,579, to be executed through Merrill Lynch on approximately 08/12/2025 on NASDAQ.
The 750 shares were acquired through restricted stock vesting in four tranches between 04/22/2024 and 04/25/2025 (60, 279, 244 and 167 shares respectively). The filing lists 24,781,558 shares outstanding and reports "Nothing to Report" for securities sold by the filer in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small insider sale of restricted shares; not likely to move market given the size relative to outstanding shares.
The filing discloses a planned sale of 750 shares valued at $190,579 via Merrill Lynch, drawn from restricted stock vesting. Against the reported 24,781,558 shares outstanding, the position represents roughly 0.003% of the float, indicating immaterial dilution or market impact. The seller reports no prior sales in the last three months. For investors, this is routine insider liquidity rather than a signal of operational change.
TL;DR: Transaction follows typical post-vesting disposal; disclosure appears complete and compliant with Rule 144 requirements.
The transaction stems from restricted stock vesting across four dates in 2024–2025, and the filer used the Form 144 mechanism to notify the market of an intended sale on NASDAQ through Merrill Lynch. The form includes the statutory attestation regarding material nonpublic information. From a governance standpoint, the filing meets procedural expectations for an insider sale of vested equity.